U.S. Navy Purchases Dry-Hematology Analyzers
By LabMedica International staff writers
Posted on 07 Sep 2010
The United States Navy is installing hematology analyzers on surface ships throughout the world.Posted on 07 Sep 2010
The QBC STAR hematology analyzers provide users a nine-parameter complete blood count through its dry-hematology approach, which eliminates the need for liquid reagents. Because of this technology, as well as the unit's small footprint and internal calibration system, the STAR can be transported easily and provide accurate patient results within minutes.
"Our line of hematology products are especially well suited for use in the military environment," commented Ken Moscone, president and CEO of QBC Diagnostics (Port Matilda, PA, USA). "With one-button operation, no start-up requirements, and the use of simple blood collection tubes, the STAR is robust, designed to go anywhere and provide results quickly. Unlike liquid reagents, dry QBC technology is not adversely affected by the pitch and roll of a ship, making it especially well-suited for use on Navy vessels."
QBC Diagnostics is a privately held company that manufactures a line of complete blood count analyzers and fluorescence microscopy products.
Related Links:
QBC Diagnostics
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
